Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS)

85 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q3 2025.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 35.7M shares of 60.7M outstanding shares and own 58.91% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (14.9M shares), Sands Capital Alternatives, LLC (3.42M shares), FRANKLIN RESOURCES INC (2.31M shares), FMR LLC (2.03M shares), VANGUARD GROUP INC (1.65M shares), Knollwood Investment Advisory, LLC (1.63M shares), Alyeska Investment Group, L.P. (940K shares), ADAR1 Capital Management, LLC (891K shares), Laurion Capital Management LP (867K shares), and Pathstone Holdings, LLC (859K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.